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Appropriate embryonic and fetal development significantly impact pregnancy success and,
therefore, the efficiency of swine production. The pre-implantation period of porcine
pregnancy is characterized by several developmental hallmarks, which are initiated by the
dramatic morphological change that occurs as pig blastocysts elongate from spherical to
filamentous blastocysts. Deficiencies in blastocyst elongation contribute to approximately
20% of embryonic loss, and have a direct influence on within-litter birth weight variation.
Although factors identified within the uterine environment may play a role in blastocyst
elongation, little is known about the exact mechanisms by which porcine (or other species’)
blastocysts initiate and progress through the elongation process. This is partly due to the
difficulty of replicating elongation in vitro, which would allow for its study in a controlled
environment and in real-time. We developed a three dimensional (3-D) culture system using
alginate hydrogel matrices that can encapsulate pig blastocysts, maintain viability and
blastocyst architecture, and facilitate reproducible morphological changes with correspond-
ing expression of steroidogenic enzyme transcripts and estrogen production, consistent with
the initiation of elongation in vivo. This review highlights key aspects of the pre-implantation
period of porcine pregnancy and the difficulty of studying blastocyst elongation in vivo or by
using in vitro systems. This review also provides insights on the utility of 3-D hydrogels to
study blastocyst elongation continuously and in real-time as a complementary and
confirmatory approach to in vivo analysis.
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[In] vitro tissue-engineering approaches provide an
exciting, more physiological alternative to traditional
two-dimenstional systems of development.
1 | HALLMARKS OF THE
PRE-IMPLANTATION PERIOD IN PIG
PREGNANCY
The pre-implantation period of porcine pregnancy is characterized by
several developmental hallmarks that are critical for the maintenance of
pregnancy, embryo spacing, placental development, fetal growth, uterine
capacity, litter size, and ultimately postnatal piglet survival. BetweenDays9
and 12 of gestation, the pig blastocyst undergoes dramatic transformation
fromaspherical structure (∼1–2mm) through transitionalovoid (∼4–5mm)
and tubular (<10mm) morphologies, to end as a long, thin filament
(<100mm); this process is referred to as blastocyst elongation (Bazer,
Geisert, Thatcher, & Roberts, 1982; Geisert, Renegar, Thatcher, Roberts, &
Bazer, 1982;Miles, Freking, Blomberg, Vallet, &Zuelke, 2008; Pope&First,
1985).Once initiated,blastocystelongation isveryrapid,with remodelingof
the trophoblast and changes in conceptus length occurring at a rate of 35–
40mmper hour onDay 11–12 (Bazer, Thatcher,Martinat-Botte, & Terqui,
1988); the morphological transition between a tubular and filamentous
blastocyst typically occurs within 2–3hr (Geisert, Renegar et al., 1982).
Unlike elongation in other domestic animals (i.e., ruminants), rapid
elongation of the pig blastocyst is primarily associated with cellular
remodeling and differentiation rather than cellular hyperplasia (Geisert &
Yelich, 1997). This mechanism is consistent with the reported potential
markers of trophectoderm (i.e., Cytokeratin-18 and Plasminogen activator
urokinase) and mesoderm (i.e., Vimentin) differentiation identified in the
elongating pig blastocyst (Blomberg, Miles, & Zuelke, 2006; Flechon,
Degrouard, &Flechon, 2004;Ka, Jaeger, Johnson, Spencer, &Bazer, 2001).
The elongating pig blastocyst produces and secretes estradiol-
17β, which serves as the key molecule for maternal recognition of
pregnancy that prevents luteolysis (Bazer et al., 1982) and
modulates the production and secretion of proteins and growth
factors within the uterus (Geisert et al., 2006). Several transcripts
involved in steroidogenesis, such as STAR (Steroidogenic acute
regulatory protein), CYP11A1 (Cytochrome P450 side chain
cleavage), and CPY19A1 (Aromatase), increase in a pattern that
is similar to estrogen production during blastocyst elongation
(Blomberg & Zuelke, 2005; Yelich, Pomp, & Geisert, 1997). Proper
interactions between the blastocyst and receptive uterine endo-
metrium are essential for supporting embryonic development and
subsequent implantation (Geisert et al., 2006). These interactions
are initiated by the immune responsive cytokine Interleukin-1β
(IL1B), which is produced by the blastocyst and uterine endome-
trium—specifically the luminal and glandular epithelia (Geisert,
Lucy, Whyte, Ross, & Mathew, 2014; Ross, Malayer, Ritchey, &
Geisert, 2003). IL1B, via its receptor, stimulates signaling that up-
regulates uterine-specific factors (e.g., Leukemia inhibitory factor
and Prostaglandin-endoperoxide synthase 2) via Nuclear factor-
kappa beta activation (Geisert, Fazleabas, Lucy, & Mathew, 2012).
Expression of these transcripts may be used as markers to assess
the developmental competence of pre-implantation porcine
blastocysts.
An elongated blastocyst begins its initial apposition with the
uterine endometrium around Day 13 of gestation (Keys & King, 1990).
Completion of blastocyst implantation occurs around Day 18 of
gestation, and is characterized by superficial attachment of the
trophectoderm and the uterine luminal epithelium (Keys&King, 1989).
Pig blastocyst elongation and subsequent implantation are dependent
on the proper interaction between embryonic and maternal tissue
(Blomberg, Hashizume, & Viebahn, 2008), which trigger uterine
endometrial transitions that result in the production and secretion
of various proteins and growth factors as well as complex interactions
between the glycocalyx of the endometrium and blastocyst that
support implantation (Burghardt, Bowen, Newton, & Bazer, 1997;
Geisert, Brookbank, Roberts, &Bazer, 1982). As a result, many uterine-
specific factors are up-regulated within the uterine milieu as the
blastocyst initiates elongation and subsequently transitions to its
superficial implantation on the uterine endometrium (Geisert et al.,
2012). For instance, Prostaglandin E, Fibroblast growth factor 7
(FGF7), Transforming growth factor-β (TGFB), Secreted phosphopro-
tein 1 (SPP1), Fibronectin, and Laminin were suggested to play a role in
these conceptus-maternal interactions (Bazer, Kim et al., 2012; Geisert
et al., 2012; Jaeger et al., 2001).
During maternal recognition of pregnancy, conceptus estradiol-
17β redirects the secretion of Prostaglandin F2α from an endocrine
secretion into the uterine vasculature to an exocrine secretion in the
uterine lumen, thereby preventing luteolytic effects of Prostaglandin
F2α (Bazer, Song et al., 2012). This transition results in extensive
accumulation of Prostaglandin F2α and Prostaglandin E in the uterine
lumen during early pregnancy (Geisert et al., 2012), which is thought to
play an important role in embryo-maternal cross-talk in the pig (Blitek,
Morawska, Kiewisz, & Ziecik, 2011).
FGF7 abundance also peaks within the uterine milieu around
Day 12 of the estrous cycle and pregnancy (Ka et al., 2007). FGF7 and
its receptor are up-regulated in the endometrial epithelium via
paracrine signaling between the conceptus (i.e., estrogen) and the
uterine stroma (i.e., progesterone) (Ka et al., 2007), and FGF7 can
stimulate proliferation and differentiation of a trophectoderm cell line
in vitro (Ka et al., 2001). Thus, uterine FGF7 is important for embryonic
development during elongation.
During the peri-implantation period of pig pregnancy (Day
10–14), expression of TGFB1, -B2, and -B3 and their respective
receptors increases within the uterine luminal epithelium and on the
conceptus (Gupta, Bazer, & Jaeger, 1996; Gupta, Dekaney, Bazer,
Madrigal, & Jaeger, 1998). This synchronized up-regulation suggests
that TGFBs are involved in embryo-maternal cross-talk (Gupta et al.,
1998). TGFBs are secreted from cells as a homodimer in a latent
complex that is associated with Latency-associated peptides (LAP),
which interact with TGFB1 and B3 containing the Arg-Gly-Asp
(RGD) amino acid sequence that binds specific integrins (Massuto
et al., 2010). Interestingly, exogenous intrauterine infusion of
recombinant LAP-RGD, beginning at Day 9 of pregnancy, decreases
conceptus survival and reduces elongation, possibly due to
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competition with endogenous LAP-TGFB (Massuto et al., 2010).
These results illustrate that conceptus elongation is likely regulated
by interactions of TGFBs and integrins (Massuto et al., 2010). SPP1,
an RGD peptide-containing extracellular matrix (ECM) glycoprotein
secreted by uterine epithelial cells, was also shown to play a role in
the porcine implantation cascade during pregnancy (Garlow et al.,
2002). Previous evidence suggested that the SSP1 RGD peptide
binds to Integrins alpha 5 and beta 3 on the embryonic
trophectoderm, inducing cytoplasmic reorganization during concep-
tus elongation by stimulating cell–cell adhesion and promoting cell
migration (Garlow et al., 2002). Furthermore, SPP1 can enhance
development of early porcine embryos to the blastocyst stage in
vitro when added exogenously to culture medium (Hao et al., 2008),
suggesting the importance of SPP1 on early embryo development.
The surface of the oviduct and uterus contains several other ECM
components that may influence embryonic development, morpho-
genesis, and function by stimulating cell–cell interactions (Adams &
Watt, 1993; Swain& Smith, 2011). Two ECMglycoproteins involved in
cellular adhesion, Fibronectin and Laminin, were previously shown to
increase the hatching rates of cultured human embryoswhen added to
the medium (Turpeenniemi-Hujanen, Feinberg, Kauppila, & Puistola,
1995). A study involving the culture of porcine blastomeres on
Fibronectin-coated culture dishes demonstrated that Fibronectin
enhanced development to the blastocyst stage compared to control
blastomeres (Saito & Niemann, 1991), suggesting its role in early
embryonic development. Further investigations of these components
are warranted to reveal how each contributes to pig blastocyst
elongation.
A significant portion of blastocysts within individual pregnancies
fail to undergo proper initiation of elongation, leading directly to
embryonic loss as well as delayed elongation, resulting in asynchro-
nous intra-litter embryo development. Deficiencies in blastocyst
elongation contribute to approximately 20% of embryonic loss (Pope,
1994), and have a direct impact on intra-litter birth weight variability
(Vallet, Miles, & Freking, 2009). Clear evidence indicates that prenatal
development has profound effects on birth weight and subsequent
postnatal survival and growth performance (Foxcroft et al., 2009),
illustrating the importance of adequate embryonic, placental, and fetal
development in regards to the pre-weaning survival of piglets (Vallet
et al., 2009). Therefore, developing a comprehensive understanding of
early embryonic mechanisms—in particular, mechanisms involved in
elongation—can lead to interventions that decrease embryonic
mortality, reduce within-litter birth weight variability, and improve
pre-weaning survival, resulting in an overall increase in the number of
healthy piglets weaned.
2 | CHALLENGES TO STUDYING
BLASTOCYST ELONGATION
Despite advances in the identification of signaling pathwayswithin the
blastocyst and uterine factors present during the pre-implantation
period of pregnancy in the pig, little is known about the exact
mechanisms by which porcine (or other species’) blastocysts initiate
and progress through elongation, due to technical and biological
challenges that prevent investigations into mechanisms of blastocyst
development. Previous studies investigating blastocyst development
in vivo utilized blastocysts flushed at various time points during the
pre-implantation period, when the developmental competence of
individual blastocysts is not entirely known and is interrupted by their
removal from the uterine environment (Miles et al., 2008). The
dramatic blastocyst diversity observed, particularly during
the transitional period (Day 10 and 11 of gestation), can also alter
the physiology of developmentally delayed blastocysts (i.e., spherical
or ovoid blastocysts) within heterogeneous blastocyst populations
(i.e., spherical, ovoid, tubular, and filamentous blastocysts) (Blomberg,
Schreier, & Li, 2010; Degrelle, Blomberg, Garrett, Li, & Talbot, 2009),
further complicating the identification of components that have
specific roles for later developmental competence of individual
blastocysts. Thus, effective in vitro culture systems that are capable
of replicating the elongation process would be useful to study
molecular factors that regulate the initiation of blastocyst elongation
aswell as allow for real-timemonitoring and studying of elongation in a
controlled environment.
Traditional studies within the field of developmental biology have
cultured blastocysts in two-dimensional (2-D) systems. The develop-
mental potential of the blastocysts in such systems is limited to pre-
elongation stages; if longer culture periods are attempted, the
blastocysts either remain in spherical form or attach to the bottom
of the dish, which disrupts embryo structure and cell-to-cell
communication, halting normal embryonic development (Brandao
et al., 2004). Such a blockade that has also been reported in 2-D
cultures of other tissues and organ systems (e.g., follicle cultures)
(Kreeger, Deck, Woodruff, & Shea, 2006; Smitz & Cortvrindt, 2002).
Cells and tissues often behave very differently when cultured in 2-D,
exhibiting major differences in gene expression compared to their in
vivo counterparts in their natural, three-dimensional (3-D) environ-
ment (Smalley, Lioni, & Herlyn, 2006).
Previous attempts to culture blastocysts at later stages by
incorporating a type of supporting structure (i.e., mimicking 3-D
cultures) were largely unsuccessful. In cattle, limited elongation of
blastocysts in vitro was demonstrated using an agar gel tube system
(Brandao et al., 2004; Vajta, Alexopoulos, & Callesen, 2004); however,
this system did not provide complete encapsulation or support of the
blastocysts. Rather, the tubes served as reservoirs for growth, and the
blastocysts filled these tubes, most likely via physical induction—that
is, the shape of the tube may have forced growth that appeared to be
elongation such that the high percentages of agar used may have
restricted optimal embryonic development. The high concentrations
of media supplements used in these bovine cultures may have
stimulated rapid cell growth, further contributing to the appearance of
embryonic elongation. Nevertheless, previous attempts to replicate
these results using pig blastocysts were unsuccessful (Vejlsted, Du,
Vajta, & Maddox-Hyttel, 2006). Our group has instead turned to
tissue-engineering principles to develop 3-D culture systems that
maintain blastocyst or tissue architecture and allow for direct physical
interaction with the surrounding environment, which better mimics in
vivo development. These in vitro tissue-engineering approaches
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provide an exciting, more physiological alternative to traditional 2-D
systems of development.
3 | TISSUE ENGINEERING APPROACHES
FOR IN VITRO CULTURE MODELS
Tissue engineering emerged at the interface of biology and engineer-
ing with the initial goal of engineering organs for patients who
otherwise were beholden to scarce donors for whole-organ trans-
plantation (Langer & Vacanti, 1993). Since Langer and Vacanti (1993)
first defined tissue engineering, it has come to combine three
fundamental aspects of biology: cells or tissues, scaffolding, and
bioactive signals (Ikada, 2006). Cells and tissues can be collected from
many sources, including animals or a patient, and the cells may be fully
differentiated or derived from stem cells (Langer & Vacanti, 1993); for
the purposes of this review, we will focus on intact blastocysts as the
cell source. The scaffolding can be used to mimic the native
extracellular matrix or environment surrounding the cells (Ikada,
2006). Finally, the bioactive signals provide the appropriate signals to
the cells or tissue within their respective scaffolding (Ikada, 2006).
Within the field of tissue engineering, researchers combine cells,
scaffolds, and bioactive signals in an attempt to engineer a variety of
tissues for therapeutic applications (e.g., bone, cartilage, skin, nerves,
trachea, bladder, and cardiovascular tissues, to name only a small few;
see review by Shafiee & Atala [2017]).
While originally developed to produce tissues for transplantation,
the principles of tissue engineering (i.e., scaffolds, cells, and provision
of bioactive signals) have now been applied to in vitro culture models
to produce biologically suitable substitutes for organ systems or
tissues, which are then utilized for pharmaceutical, diagnostic, or
research purposes (Nam, Smith, Lone, Kwon, &Kim, 2015)—essentially
bridging the gap between traditional 2-D cell culture and animal
studies (Figure 1). Most tissue-engineered models are developed and
constructed for a specific purpose using cells of many different types,
scaffolds made of varying materials, and a wide range of bioactive
signals. Applications for in vitro culture models include the exploration
of various aspects of disease dynamics, drug discovery, diagnostics,
and developmental biology.
Recently developed 3-D culturemodels have already proven to be
more physiologically relevant than either cell culture or animal models,
and have demonstrated improved responses to controlled stimuli
(Antoni, Burckel, Josset, & Noel, 2015). For example, 3-D in vitro
culture models are extensively used to study cancer and metastasis, as
well as other diseases, and have probed for the response of tissues to
therapeutic and pharmacological agents (Burgues et al., 2007;
Jaganathan et al., 2014; Song, Park, & Gerecht, 2014; Wang et al.,
2014). Models of cancers in the bladder, breast, kidney, lung, ovary,
pancreas, and prostate have utilized 3-D in vitro cultures to better
understand the development, metastasis, vascularization, and re-
sponse to therapeutic drugs (Dash et al., 2009; Gilmour, Woolley,
Poole-Warren, Thomson, & Green, 2016). Pampaloni, Reynaud, and
Stelzer (2007), for instance, used 3-D cultures with reconstituted
basement membrane, or Matrigel, plus bioactive signals to show the
significant role of the extracellular context in tumorigenesis
(Pampaloni et al., 2007). Osteoarthritis has also been studied in vitro
to understand the degradation and calcification of articular chon-
drocytes by treating with factors known to be involved in the
disruption of articular cartilage (Cortial et al., 2006). Tissue-engineered
3-D models of gastrointestinal inflammatory disease, rheumatoid
arthritis, heart disease, and of many more organ-system disorders
helped identify biomarkers, such as gene expression and protein
secretion reminiscent of the tissue disease, that their monolayer
counterparts were unable to achieve (Cortial et al., 2006; Eschenhagen
et al., 1997; Hartman et al., 2014; Smolian et al., 2001).
3-D culture models have utilized a variety of scaffold materials
that were carefully chosen to mimic the appropriate biomechanical,
biophysical, andmolecular interactions that occur in vivo. For example,
we chose alginate as the hydrogel scaffold system for studying pig
blastocyst elongation (Sargus-Patino et al., 2014). Alginate is used in
many tissue-engineering applications—including injectable cell deliv-
ery vehicles (Atala, Kim, Paige, Vacanti, & Retik, 1994), wound
dressings (Rezvanian, Amin, & Ng, 2016), and matrices for a variety of
tissues (e.g., cartilage, bone, pancreatic islets [Lee &Mooney, 2012])—
because of its biocompatibility, tunable mechanical properties, and
easy modification (Lee & Mooney, 2001), which will be discussed
further in the next section.
4 | ALGINATE
4.1 | Structure and properties
Hydrogels—networks of hydrophilic polymer chains with high water
content—are highly appealing as 3-D scaffolds for in vitro cell and
tissue culture due to their ability to mimic the physical properties of
native soft tissue (Tibbitt & Anseth, 2009) as well as their high porosity
for efficient diffusion of proteins and nutrients (Smidsrod & Skjak-
Braek, 1990). Alginate hydrogels, in particular, are widely applied in
tissue engineering due to their desirable properties as a biomaterial
(Lee & Mooney, 2001). Alginate is a biocompatible, naturally derived,
linear polysaccharide produced as an ECM component in brown algae,
such as Macrocystis pyrifera and Ascophyllum nodosum, and some
bacteria, such as Pseudomonas aeruginosa (Gacesa, 1998; Ueno &Oda,
2014). The polysaccharide is composed of repeating units of β-D-
mannuronic acid (M) and α-L-guluronic acid (G) residues, and forms
hydrogels by ionic cross-linking of the G residues in the presence of a
divalent cation like calcium (Figure 2) (Andersen, Strand, Formo,
Alsberg, & Christensen, 2012; Lee & Mooney, 2001).
Anexternal gelationprocess allows for gentle encapsulationof cells
and tissue without negatively affecting cell viability. The alginate gel
forms a mesh-like structure with pore sizes ranging from 5 to 200 nm,
which permits the diffusion of proteins and hormones that are essential
for cell and tissue growth and development (Gombotz & Wee, 1998;
Smidsrod&Skjak-Braek, 1990). Increasing the concentrationof alginate
in gels decreases the rate of diffusion of proteins through the pores
(Gombotz & Wee, 1998). Since only the G residues of alginate
participate in intermolecular cross-linking to form the hydrogels
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(Figure 2), theM-to-G ratio has a significant impact on themechanics of
cross-linking (Lee & Mooney, 2001). Thus, gels made of alginate with a
high G content have the most open-pore structure and allow the
greatest rate of protein diffusion (Smidsrod & Skjak-Braek, 1990). In
addition to its gentle encapsulation process and diffusion capabilities,
alginate exhibits negligible non-specific protein absorption or cell
adhesion, leading to minimal interaction between encapsulated cells/
tissueand the surrounding alginatehydrogels (Rowley,Madlambayan,&
Mooney, 1999). This feature allows alginate to provide a “blank slate,”
acting only as a mechanical support system to study the effects of 3-D
culture without any other interference; however, varying the concen-
trationofalginatealters themechanical propertiesof thematrix, andcan
be used to evaluate the effect of matrix mechanics on cell and tissue
growth (West, Xu, Woodruff, & Shea, 2007).
Degradation of alginate hydrogels does not readily occur under
physiological conditions (Kong, Kaigler, Kim, & Mooney, 2004),
although unmodified calcium-cross-linked alginate hydrogels slowly
and uncontrollably disassemble due to ion exchange (Shoichet, Li,
White, & Winn, 1996). Increased rates of degradation requires the
presence of chelating agents that accelerate the removal of calcium
ions from the matrix, such as ethylenediaminetetraacetic acid (EDTA),
lactate, citrate, or phosphate, (Gombotz & Wee, 1998). No known
alginate-degrading enzymes exist inmammals, but alginate lyases have
been isolated from marine algae and a wide variety of microorganisms
(Andersen et al., 2012). Alginate lyases degrade the matrix via
β-elimination, in which the glycosidic 1–4 O-linkage between
monomers is cleaved (Wong, Preston, & Schiller, 2000). These
properties make alginate hydrogels an appropriate material for
FIGURE 1 The principles of in vitro culture models. Tissue-engineering techniques using the combination of cells, scaffolds, and signals are
utilized to develop in vitro culture models that bridge cell culture and animal models, giving researchers another tool for studying
pharmaceutical, diagnostic, or developmental mechanisms
FIGURE 2 Chemical structure and ionic cross-linking of alginate. Alginate is made of repeating β-D-mannuronic acid (M) and α-L-guluronic
acid (G) residues that are ionically cross-link via divalent cations, such as Ca2+, to form hydrogels. Modified from Andersen et al. (2012)
MILES ET AL. | 779
maintaining the structural integrity during extended culture of
encapsulated mammalian cells and tissues. Furthermore, alginate
lyase or chelating agents can readily be used to retrieve cells or tissue
from alginate beads for further assays.
4.2 | Modulation of alginate mechanical properties
The ability to control the mechanical properties of biomaterials used
for in vitro culture is essential because tissues have a broad range of
stiffness. The Young’s moduli (i.e., the stiffness) of alginate hydrogels
can be modified by changing the concentration of alginate in solution,
the chemical makeup of the alginate molecule, the solvent used to
dissolve the alginate, the gelation temperature, and the divalent cation
used for cross-linking (Drury, Dennis, &Mooney, 2004;Morch, Donati,
Strand, & Skjak-Braek, 2006; West et al., 2007). The compressive
modulus for alginate hydrogels can range from less than 1-kPa to over
1,000-kPa, wherein lower moduli can be used to mimic ECM for
tissues like smooth muscle while higher moduli can be used in
applications for bone tissue engineering. The development of alginate
hydrogels for the culture of porcine blastocysts (described later in this
review) employed alginate hydrogels with a Young’s modulus ranging
from 5- to 20-kPa, which were prepared by varying density (w/v) of
medium-viscosity (>200mPa) alginate (Figure 3). Although the
mechanical properties of alginate can be varied with relative ease,
chemicalmodification of the alginatemolecule and hydrogels are often
required to extend the stability of calcium cross-linked alginate
hydrogels, provide controlled release of encapsulated factors, provide
greater range of mechanical properties, and promote desirable cellular
functions.
4.3 | Chemical modifications of alginate
Alginate’s free hydroxyl and carboxyl groups (Figure 2) provide
numerous sites that are ideal for chemical modifications. Properties
such as degradability, controlled release of factors, and biological
characteristics can be altered by modifying available hydroxyl and/or
carboxyl groups, or by interfering with carbon-carbon bonds (Yang,
Wie, & He, 2011). The addition of oxidation points to the alginate
molecule, by using γ-radiation and/or periodate oxidation, lowers the
molecular weight of the polysaccharide, thus allowing for strict
regulation of alginate hydrogel degradation rate without changing its
initial physical properties (Boontheekul, Kong, & Mooney, 2005; Kong
et al., 2004). Another useful chemical modification of alginate is
sulfation, in which alginate is reacted with chlorosulfuric acid in
formamide (Yang et al., 2011). This process gives alginate a structural
similarity to heparin, especially mimicking heparin’s high affinity for
certain growth factors—a property that was exploited to provide
protection and sustained release of heparin-binding growth factors,
such as basic Fibroblast growth factor, which is valuable for in vivo
delivery systems and tissue-engineering applications (Freeman,
Kedem, & Cohen, 2008).
Mammalian cells do not normally adhere to alginate polymers,
which make alginate relatively inert; however, interactions with
extracellular ligands are necessary for cell adhesion, which is a basic
requirement of cellular survival, migration, proliferation, and differen-
tiation (Price, 1997; Rowley et al., 1999). Cellular surface receptors,
such as integrins and syndecans, bind to cell adhesion molecules such
as Collagens, Fibronectin, Laminin, and SPP1, resulting in physiological
changes that support cell survival, migration, proliferation, and
differentiation (Burghardt et al., 2009; Takahashi et al., 2007). These
ECMmolecules are easily blended within the alginate solution prior to
cross-linking, thus incorporating them within the hydrogels and
providing physiological changes to cells consistent with in vivo
phenotypes (Kreeger et al., 2006). Amidation is another functional
modification of alginate that promotes cell-alginate interactions (Yang
et al., 2011). This modification utilizes carbodiimide chemistry to form
amide linkages between amine-containing molecules and the carbox-
ylic acid functional groups of the alginate polymer backbone (Rowley
et al., 1999). This chemistry is useful for covalently linking specific
peptides to the alginate backbone to promote cell adhesion
interactions (Rowley et al., 1999). The RGD peptide sequence is
found in many ECM proteins, such as Fibronectin, Laminim, and SPP1,
that is effective and commonly used to promote cell adhesion (Hersel,
Dahmen, & Kessler, 2003). When covalently linked to alginate, RGD
peptide sites serve as ligands for cell-surface integrins, thus promoting
cell adhesion and migration; ligand density can be varied to produce
desired degrees of adhesion (Rowley et al., 1999). These unique
physical and chemical properties of alginate, along with its innate
biocompatibility, underlie its extensive use in industrial food,
biomedical, and tissue-engineering applications.
4.4 | Applications for alginate hydrogels
Alginate is commonly used as a thickening agent to increase the quality
of foods, such as ice cream and dressings, due to it biocompatibility and
low toxicity (Andersen et al., 2012). It is also widely used in the
pharmaceutical industry as a drug- andprotein-delivery agent, whereby
alginate hydrogels can release macromolecules in a controlled manner
andcanbeorally administeredor injectedusinganon-invasiveapproach
FIGURE 3 Young’s modulus as a function of alginate concentration
for unmodified (black circles) and RGD-conjugated (red triangle) alginate
hydrogels. The plotted lines display the linear, best-fit equations for
both alginate conditions. (Unmodified alginate, R2 = 0.9375; RGD-
alginate, R2 = 0.9981)
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(Lee & Mooney, 2001). The extensive application of alginate in tissue
engineering is due to its biocompatibility, relatively low cost, and gentle
gelation process (Andersen et al., 2012; Lee &Mooney, 2001); alginate
hydrogels were previously used for the encapsulation and culture of a
variety of cell types for tissue engineering, including articular
chondrocytes (Alsberg, Anderson, Albeiruti, Rowley, & Mooney,
2002), skeletal myoblast (Rowley et al., 1999), neural stem cells (Purcell,
Singh, & Kipke, 2009), and mouse embryonic stem cells (Candiello,
Singh, Task, Kumta, & Banerjee, 2013).
In addition to cellular encapsulation for transplantation, alginate
hydrogels have been utilized as a 3-Dmatrix for the in vitro culture of a
variety of organs and embryos (Elsheikh, Takahashi, Hishinuma, Nour,
& Kanagawa, 1997; Sargus-Patino et al., 2014; Subramanian et al.,
2010; Xu, Kreeger, Shea, & Woodruff, 2006; Zhao et al., 2015). For
example, alginate hydrogels were previously used to support the in
vitro development of ovarian follicles in mice (Kreeger et al., 2006;
West et al., 2007) and non-human primates (Xu et al., 2009);
cryopreserved-thawed human cortical follicles (Kedem et al., 2011);
and sections of ovaries and oviducts to model specific changes that
might lead to ovarian cancer (Xu, West, Shea, & Woodruff, 2006).
Alginate hydrogels were also successfully applied for the in vitro
development of mouse pronuclear-stage embryos (Elsheikh et al.,
1997) and bovine embryos up to the blastocyst stage (Yaniz,
Santolaria, & Lopez-Gatius, 2002). Therefore, alginate hydrogels
have a proven, significant potential as an artificial 3-D matrix for
the in vitro culture of pre-implantation blastocysts. As such, we utilized
tissue-engineering principles to develop a 3-D culture system using
alginate hydrogels to encapsulate and support in vitro porcine
blastocyst elongation (Sargus-Patino et al., 2014). This culture system
was recently adapted by other groups to investigate embryonic
development in human (Arjmand et al., 2016) and bovine blastocysts
(Zhao et al., 2015). The remainder of this review will highlight our
alginate culture system and illustrate the utility of 3-D hydrogels to
study porcine blastocyst elongation continuously and in real time.
5 | CULTURE OF PORCINE BLASTOCYSTS
IN ALGINATE HYROGELS
5.1 | Alginate hydrogel design
The principal purpose of a tissue-engineering scaffold is to provide a
framework and space in which tissue growth can occur that mirrors its
native environment (Drury & Mooney, 2003). The physical properties
of the scaffold are essential to dictate the direction in which tissue
growth proceeds and how cell/tissue architecture is maintained.
Several methods were investigated to create alginate hydrogels that
could support the in vitro culture of pre-implantation porcine
blastocysts. Four encapsulation techniques were initially tested to
identify the optimal approach for pre-implantation porcine
blastocysts.
The first technique was a simple “drop” method, similar to how
ovarian follicles were encapsulation (Kreeger et al., 2006; Shikanov,
Xu, Woodruff, & Shea, 2011), in which 0.5- to 1-mm porcine
blastocysts were placed in a 25-μl drop of alginate solution that
was slowly released from the edge of a wide-orifice pipette tip into
cross-linking solution (50mM CaCl2,140mM NaCl) for 3min. This
formed a single bead ∼3–4mm in diameter that contained an
individual, encapsulated blastocyst. We tested encapsulation of
blastocysts in various concentrations of alginate solution (0.3%,
0.7%, and 1.5%) to investigate the role of scaffold mechanics on
development over the next 96 hr. Although blastocyst survival did not
vary among the different alginate concentrations, only limited
morphological changes were observed in the 0.7% alginate solution
(personal observation). One significant problem with this single-drop
technique was that a significant percentage of blastocysts (>50%) did
not remain encapsulated within the hydrogels after 24 hr of culture, as
the majority of the blastocysts were initially encapsulation at the edge
of the bead and eventually dissociated from the bead.
Two additional techniqueswere tested in an attempt to ensure full
encapsulation of the blastocysts within the hydrogel. First, an internal
gelation method using a calcium slurry (Andersen et al., 2012) was
utilized in an attempt to better position the blastocysts within the
hydrogels. For this technique, various alginate solutions (0.3%, 0.7%,
and 1.5%) were placed in CaSO4, creating an alginate/calcium slurry
prior to inserting blastocysts. Gelation of the hydrogels occurs as the
calcium slowly leaks from the alginate solution (Andersen et al., 2012).
Although this method allowed for precise positioning into the alginate
hydrogels, none of the blastocysts survived the culture period
(personal observation). This negative outcome was likely due to the
reduction in pH that occurs as calcium is slowly released, and may be
harmful to cells within the alginate solution during gelation (Andersen
et al., 2012). The next technique used a combination of both the single-
drop and calcium slurry techniques wherein the hydrogels were
completely cross-linked prior to inserting a blastocyst into the
hydrogel using a 14-gauge needle. This approach improved placement
of the blastocysts within the hydrogels, thus ensuring that the
blastocysts remained encapsulated throughout the culture period.
Unfortunately, none of the blastocysts survived the culture period
using this precast technique (personal observation), likely because of
the trauma they experienced during their placement into the precast
hydrogels.
The final encapsulation technique developed (and currently used
in our lab today) is an extension of the single-drop encapsulation
technique that includesmultiple layers of alginate hydrogels (Figure 4),
referred to as double encapsulation (Sargus-Patino et al., 2014). The
blastocyst is first placed in 25-μl drop of alginate solution. This alginate
droplet containing the blastocyst is then dropped into the cross-linking
solution (50mMCaCl2, 140mMNaCl), using awide-orifice pipette tip,
for 3 min. The encapsulated blastocyst in the single-layer alginate bead
is transferred to a new 45-μl drop of alginate solution, and the cross-
linking process is repeated, yielding a blastocyst encapsulated with
two layers of alginate hydrogel. This technique resulted in >95% of
blastocysts remaining encapsulated throughout the culture period
(personal observation). Furthermore, survival and morphological
changes were consistently observed using this technique. Further-
more, blastocysts exhibitingmorphological changes during culture (i.e.,
initiation of elongation) would typically migrate out of the hydrogels
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(see below). As a result, double encapsulation was the primary
technique chosen to assess the development of pre-implantation
porcine blastocysts in vitro within alginate hydrogels.
5.2 | Development of porcine blastocysts in alginate
hydrogels
Our first study using the double-encapsulation method evaluated in
vitro development of encapsulated porcine blastocysts by characteriz-
ing cellular survival, morphological changes, gene expression of
steroidogenic enzyme and immune-response transcripts, and estra-
diol-17β production (Sargus-Patino et al., 2014). In this study, spherical
pig blastocysts∼1mm indiameter recovered atDay9of gestationwere
either encapsulated using the double-encapsulation method (Figure 4),
in 0.7% alginate hydrogels (ENC), or remained non-encapsulated as
controls (CONT), and then cultured for 96 hr in serum-based medium.
Although no differences in cell survival were observed between the
ENC and CONT blastocysts, 32% of surviving ENC blastocysts
underwent morphological changes, such as tubal formation with
subsequent flattening (Figure5),whereasnoneof theCONTblastocysts
exhibited morphology changes. In addition, the abundance of tran-
scripts for steroidogenic enzymes (STAR, CYP11A, and CYP19A) was
higher in blastocysts that were encapsulated and had morphological
changes (ENC+) compared to blastocysts encapsulated with no
morphological changes observed (ENC−) or non-encapsulated CONT
blastocysts. The expression of these steroidogenic enzyme transcripts
in ENC+ blastocysts was consistent with observed increases in later-
stage in vivo-produced blastocysts (i.e., ovoid and tubular blastocysts)
that have initiated the elongation process (Blomberg, Garrett et al.,
2006; Sargus-Patino et al., 2014). Similarly, ENC+ blastocysts produced
and secretedmore estradiol-17β at 72 and 96 hr of culture compared to
CONT and ENC− blastocysts. This increased production and secretion
of estradiol-17β by ENC+ blastocysts was also similar to what is
observed from later-stage in vivo-produced blastocysts (i.e., ovoid and
tubular blastocysts) (Miles et al., 2008), and further illustrated that
alginate hydrogels can support successful initiation of elongation using
only basal-medium conditions (Sargus-Patino et al., 2014).
Proper interactions between the blastocyst and receptive
uterine endometrium are essential for supporting embryonic
development and subsequent implantation (Ross et al., 2003). These
interactions are initiated and regulated by the immune-response
cytokine IL1B (Ross et al., 2003). Although the abundance of IL1B
mRNA was greater in ENC+ blastocysts compared to CONT
blastocysts, its expression was decreased in ENC+ compared to in
vivo-produced tubular blastocysts (Sargus-Patino et al., 2014). This
difference suggests that direct interaction with the maternal
endometrium and specific factors within the maternal milieu are
required for the up-regulation of IL1B expression in the blastocyst,
whereas up-regulation of steroidogenic enzyme transcripts and
estradiol-17β production may be independent of maternal-embry-
onic crosstalk. These data suggest that additional factors, either
specific soluble factors or components of the ECM, may be
necessary to elicit the appropriate maternal-embryonic crosstalk
required for progression through the elongation process. Therefore,
modifications to the alginate hydrogel culture system, such as
addition of soluble and ECM factors, could improve the system for
evaluating and understanding specific mechanisms of blastocyst
elongation.
FIGURE 4 Schematic of the formation of alginate hydrogel beads, in conjunction with the encapsulation of blastocysts. (a) Single
encapsulation, resulting in a blastocyst encapsulated within one layer of alginate hydrogel. (b) Double encapsulation, resulting in a blastocyst
encapsulated within two layers of alginate hydrogels
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5.3 | Incorporation of soluble factors into the
alginate hydrogel culture system
Dramatic changes in protein content within the uterine environment
occur during the estrous cycle and early pregnancy in the pig (Roberts &
Bazer, 1988). Interestingly, only limited differences in proteins within
the uterinemilieu are observed betweenDays 10 and 13 of the estrous
cycle and pregnancy, illustrating that many of these proteins are
produced and secreted by the endometrium independent of the
conceptus (Kayser, Kim, Cerny, & Vallet, 2006). Much of the uterine
proteinproduction andsecretions are influencedbyprogesterone levels
during early estrous cycle and pregnancy (Vallet, Christenson, Trout, &
Klemcke, 1998), which illustrates the importance of early-cycle
progesterone priming on uterine receptivity of implantation and
corresponding pregnancy success (Bazer, Spencer, Johnson, Burghardt,
&Wu, 2009). Asynchronous embryo transfermodels in pigs (Wilde, Xie,
Day, & Pope, 1988) and cattle (Ledgard, Berg, McMillan, Smolenski, &
Peterson, 2012) revealed that exposure of embryos to specific uterine
environments (i.e., a 1- to 2-day delayed or an advanced uterine
environment in relationship to the embryo) highly influenced subse-
quent embryonic development and survival. As a result, appropriate
timing for the presentation of uterine factors is critical for proper
conceptus development and subsequent implantation.
Given these observations, we tested whether cellular survival or
morphological changes could be achieved by culturing alginate-
encapsulated pig blastocysts (∼1mm) for 96 hr in a serum-free
RPMI-1640 medium containing purified uterine proteins (3.5 mg/ml)
collected from either Day 9 or 10 pregnant gilts. No difference in
blastocyst survival was observed between the CONT blastocysts or
those ENC blastocysts cultured in medium containing uterine proteins
compared to those cultured in standard serum-based medium
(traditional RPMI-1640 medium containing 10% FBS) (Table 1). In
addition, no differences were observed for morphological changes
between ENC blastocysts cultured with uterine protein from Day 9 or
10 pregnant-uterine flushings or with standard serum-containing
medium. As before, CONT blastocyst did not undergo any morpho-
logical changes. Thus, culturing encapsulated blastocysts within
serum-free medium containing uterine proteins from Day 9 and 10
of gestation is sufficient tomaintain blastocyst survival and to facilitate
morphological changes in vitro.
TGFBs are also thought to play a key role in porcine blastocyst
elongation and subsequent implantation (Gupta et al., 1996, 1998;
Massuto et al., 2010). As such, we successfully cultured blastocysts for
96 hr using our alginate hydrogel encapsulation system with the
addition of various concentrations of commercial, recombinant TGFB1
(R&D Systems, Minneapolis, MN) within traditional serum-based
culture medium. Although no significant difference in morphological
change was observed in this preliminary study (a low sample size of 33
total cultured blastocysts were tested), combining the encapsulated
groups treated with various concentrations of TGFB1 (0, 0.1, or
1.0 ng/ml) demonstrated a tendency for morphological changes in
ENC blastocysts compared to CONT blastocysts (Table 2), implying
that TGFB1 created a culture medium environment that facilitated
morphological changes, as indicated by the percent of surviving
blastocysts that initiated morphological change. Thus, our culture
system can be used to specifically test if and how soluble factors affect
blastocyst elongation and development.
5.4 | Incorporation of ECM factors into the alginate
hydrogel culture system
Wechemicallymodified the alginate hydrogels by covalently attaching
RGD peptides to the alginate polymer backbone using carbodiimide
chemistry, as previously described (Rowley et al., 1999), to ask if the
addition of ECM factors into our established alginate hydrogel culture
system benefits elongation (Sargus-Patino et al., 2014). We success-
fully cultured blastocysts for 96 hr encapsulated in unmodified
alginate, alginate conjugated with RGD, and with 0.1 μg/ml SPP1
incorporated in the alginate (Laughlin et al., 2017). At the termination
of culture, overall survival was greater for blastocysts encapsulated in
hydrogels conjugated with RGD and those supplemented with SPP1
compared to non-encapsulated controls and those encapsulated in
unmodified alginate. Furthermore, the proportion of blastocysts that
underwent morphological change was greater for those encapsulated
FIGURE 5 Representative images of non-encapsulated control blastocyst and encapsulated blastocyst in 0.7% alginate hydrogel during 96 hr
of culture. (a) Non-encapsulated control blastocyst. (b) Encapsulated blastocyst. Live/dead staining was performed using a standard protocol
at the termination of the culture. When the encapsulated blastocyst was removed from alginate prior to live/dead staining, it separated at the
elongated junction. Scale bar, 1 mm. Modified, with permission, from Sargus-Patino et al. (2014)
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in hydrogels conjugatedwith RGD compared to the standard (alginate-
only) hydrogels. Cellular proliferation did not differ between these
treatments, which supports previous literature reporting that mor-
phological changes during elongation are not primarily driven by
hyperplasia, but rather by cellular reorganization (Geisert & Yelich,
1997). Interestingly, only blastocysts encapsulated within RGD-
hydrogels exhibited both increased abundance of transcripts for
steroidogenic enzymes (i.e., STAR and CYP19) and immune-response
genes (i.e., IL1B) and increased estradiol-17β production, consistent
with blastocysts undergoing elongation in vivo (Laughlin et al., 2017).
Thus, blastocysts encapsulated in alginate hydrogels conjugated with
RGD or supplemented with SPP1 showed improved development in
vitro compared to non-encapsulated control blastocysts and to those
in a standard alginate hydrogel. Furthermore, the presence of RGD
conjugation within the hydrogel improved blastocyst development in
terms of the proportion of blastocysts undergoing morphological
changes, as well as eliciting appropriate maternal-embryonic crosstalk
(i.e., up-regulation of IL1B).
6 | CONCLUSIONS
Tissue-engineering approaches provide innovative, more-physiological
alternatives to traditional 2-D systems for in vitro models of
development. We developed a 3-D culture system using alginate
hydrogel matrices that can encapsulate pig blastocysts, maintain
viability and blastocyst architecture, and facilitate morphological
changes that are compatible with the initiation of elongation in vivo,
thus allowing us to study the initial stage of blastocyst elongation in real
time. This approach should serve as a complementary and confirmatory
approach to in vivo analysis, with the benefit of controlledmanipulation
using exogenous factors. Further investigations with our 3-D culture
system will focus on the effects of certain growth factors, hormones,
ligands, ECM components, and uterine epithelial cell interactions on the
development of preimplantation porcine blastocysts and on developing
strategies to improve pregnancy outcomes in the pig by identifying
mechanisms to decrease embryonic mortality, reducewithin-litter birth
weight variability, and improve pre-weaning survival. Our alginate
culture system can also be applied to study blastocysts elongation by
other ungulate species (Zhao et al., 2015), such as cattle and sheep, to
identify and compare potential regulators of normal embryonic
development among animals.
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TABLE 2 Summary of embryo survival and observedmorphological changes following 96 hr of culture of either non-encapsulated control porcine
embryos or porcine embryos double encapsulated in 0.7% alginate hydrogels and cultured in various concentrations of recombinant TGFB1 (0, 0.1,
and 1.0 ng/ml TGFB1)1,2
CONT ENC (0) ENC (0.1) ENC (1.0) p-value
Number of embryos 9 8 8 8
Embryo survival (%)3 55.6 ± 16.6 75.0 ± 15.3 62.5 ± 17.12 50.0 ± 17.7 0.96
Morphological change from all embryos (%) 0c 37.5 ± 17.1d 37.5 ± 17.1d 37.5 ± 17.1d 0.37
Morphological change from surviving embryos (%) 0c 50.0 ± 20.4d 60.0 ± 21.9d 75 ± 21.7d 0.19
1Values are reported as least-squares means ± standard error, as determined using GLIMMIX analysis for the main effect of treatment (i.e., control vs.
encapsulated embryos and cultured in various concentrations of recombinant TGFB1 (0, 0.1, and 1.0 ng/ml). c,dSignificance (p < 0.08) for the effect of
treatment (combining all ENC groups) was determined using chi-square analysis.
2Unpublished data.
3Assessed by blastocyst fragmentation.
TABLE 1 Summary of embryo survival and observedmorphological changes following 96 hr of culture of either non-encapsulated control porcine
embryos or porcine embryos double encapsulated in 0.7% alginate hydrogels and cultured in media containing
RMPI–1640 + day 9 uterine protein (d9), + day 10 uterine proteins (d10), or +10% serum (Ser)1,2
CONT ENC (Day 9) ENC (Day 10) ENC in Serum p-value
Number of embryos 40 43 43 43
Embryo survival (%)3 52.5 ± 7.9 48.8 ± 7.6 51.2 ± 7.6 48.8 ± 7.9 0.99
Morphological change from all embryos (%) 0a 11.6 ± 4.9b 14.0 ± 5.3b 12.2 ± 5.1b 0.17
Morphological change from surviving embryos (%) 0a 23.8 ± 9.3b 27.2 ± 9.5b 25.0 ± 9.7b 0.16
1Values are reported as least-squares means ± standard error, as determined using GLIMMIX analysis for the main effect of treatment (i.e., control vs.
encapsulated embryos in Day-9 uterine protein, Day-10 uterine protein, or 10% serum-based medium). a,bSignificance (p < 0.05) for the effect of treatment
was determined using chi-square analysis.
2Unpublished data.
3Assessed by blastocyst fragmentation.
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